The global antiparasitic drugs market is projected to grow from $23.3 billion in 2026 to $30.98 billion by 2032, driven by persistent parasitic diseases, drug resistance, and climate change. Innovations focus on resistance-ready therapies, pediatric and pregnancy-safe formulations, and AI-enabled drug discovery and surveillance. Africa and Asia-Pacific lead demand due to endemic diseases, while developed regions address imported infections. Companies must prioritize quality, diagnostic partnerships, and resilient supply chains to meet evolving global health needs.
The U.S. Bankruptcy Court for the Central District of California confirmed the Plan of Liquidation for Oceanwide Plaza LLC, enabling the $470 million sale of the stalled Downtown Los Angeles development to KPC Square, a joint venture between KPC Grou...
General Motors will report its second-quarter earnings before the market opens, with analysts expecting adjusted earnings per share of $3.20 and revenue of $47.01 billion. This would represent a 26% increase in earnings per share but a slight 0.2% de...
Bitcoin long-term holders have decreased their selling losses to about 6%, improving from a previous 27% loss, signaling less panic in the market. Despite this, Bitcoin has yet to show strong bullish momentum as rising oil prices and inflation concer...
Bombardier announced that its Global 8000 business jet has received an Environmental Product Declaration (EPD), joining other models like the Challenger 650 and Global 7500. This makes Bombardier the only business jet maker to publicly disclose the f...
Forward Industries, Inc. officially announced that it has no intention to make a takeover offer for Brera Holdings plc, complying with Rule 2.8 of the Irish Takeover Rules. This statement legally binds Forward and its associates to these terms for si...
